Novel device offers hope for rheumatic heart disease patients

Novel device offers hope for rheumatic heart disease patients

Johannesburg, Sep 10 (IANS) Researchers have developed a new heart valve replacement device that does not require advanced cardiac surgical facilities or sophisticated cardiovascular imaging and offers hope for the thousands of patients suffering from rheumatic heart disease.

Rheumatic heart disease is caused by rheumatic fever, which results from a streptococcal infection. Patients develop fibrosis of the heart valves, leading to valvular heart disease, heart failure and death.

“Over the past decade heart valve surgery has been revolutionised by transcatheter aortic valve implantation (TAVI), where heart valves are replaced or repaired via a catheter, obviating the need for open heart surgery or a heart-lung machine,” said lead author Jacques Scherman, Cardiac Surgeon at the University of Cape Town, South Africa.

The team developed a novel TAVI device which is “non-occlusive”, meaning that there is no need to stop blood circulating to the body with rapid ventricular pacing — quick heart beats.

The device is also “self-locating” and does not require sophisticated cardiac imaging for positioning.

Testing the device in a sheep model, the team found that the device was easy to use and positioned the valve correctly, and the procedure could be performed without rapid ventricular pacing.

“We showed that this new non-occlusive, self-locating TAVI delivery system made it easy to perform transcatheter aortic valve replacement,” Scherman said.

“Using tactile feedback the device is stabilised in the correct position within the aortic root during the implantation. It also has a temporary backflow valve to prevent blood leaking backwards into the ventricle during the implantation of the new valve,” Scherman explained.

All these factors together allowed for a slow, controlled implantation compared to the currently available balloon expandable devices.

Further, this simplified approach to transcatheter aortic valve replacement could be done in hospitals without cardiac surgery at a fraction of the cost of conventional TAVI.

It has the potential to save the lives of the large numbers of rheumatic heart disease patients in need of valve replacement, the researchers said.

The findings were presented at the SA Heart Congress 2016, in Cape Town recently.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here